Active-ingredient Dossier
Escitalopram Oxalate
Active-ingredient Dossier for Escitalopram Oxalate (selective serotonin reuptake inhibitor). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: LEXAM
- Brand: LEXAPRO
- Brand: LOXALATE
- Brand: APX-ESCITALOPRAM
- Brand: ESCITALOPRAM GH
- Brand: ESCITALOPRAM-WGR
- Therapeutic area: Psychiatry
What is
Escitalopram Oxalate Escitalopram Oxalate is a selective serotonin reuptake inhibitor.
Australian brands containing
Escitalopram Oxalate — LEXAPRO — LOXALATE — APO-ESCITALOPRAM — APX-ESCITALOPRAM — BLOOMS — CILOPAM-S — ESCICOR — ESCITALOPRAM GH — ESCITALOPRAM SANDOZ — Escitalopram-TIH — ESCITALOPRAM-WGR — LEXAM
Therapeutic areas
Escitalopram Oxalate is registered in Neurology (23 brands) and Psychiatry (1 brand).
Sponsor landscape
The ingredient is marketed by twelve sponsors: Arrotex Pharmaceuticals, Alphapharm, Micro Labs, Ipca Pharma, Cipla, and Strides Pharma Science.
PBS and regulatory activity
Two brands with this ingredient have PBAC outcomes on record, with the latest outcome recorded on 1 July 2014. No brands with Escitalopram Oxalate have AusPARs on record.